The global communications leader, who previously held roles at Eli Lilly and Kaiser Permanente, joins the world’s leading consumer health platform in its next phase of growth
Hims & Hers shares surged 46% after partnering with Novo Nordisk to offer FDA-approved Ozempic and Wegovy, moving away from compounded GLP-1 alternatives.
The program debuts with Prenuvo and Eight Sleep, providing discounts on advanced diagnostics and sleep technology
March S&P 500 E-Mini futures (ESH26) are down -0.15%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.14% this morning, giving up earlier gains driven by President Trump’s remarks on the Iran...
The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.71%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.13%. March E-mini...
Hims & Hers shares soared as Novo Nordisk dropped its GLP-1 lawsuit. But there’s reason to still sell HIMS stock today. Find out more!
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti , LLC (“KSF”), announces that KSF has commenced an investigation into...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.7%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -1.0%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.4%. March E-mini S&P futures (ESH26...